Please see Terms of Reference linked below which outlines the key background information, purpose and suggested content, process and timeline to develop a Statement on Menopause by IPPF’s International Medical Advisory Panel (IMAP).
This IMAP statement is expected to provide IPPF member associations with appropriate recommendations for how to support the provision of rights-based and person-centred care for women and others experiencing menopause, perimenopause and premature menopausal symptoms. This statement will also serve as a tool for advocacy for increased awareness and availability of treatment options for menopause.
Interested consultants are advised to send their CV and list of relevant publications to Dr Nathalie Kapp, Chief Medical Advisor at IPPF via email: [email protected] by the 13th December 2023.
